Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 18.94 EUR 0.37% Market Closed
Market Cap: 18.6B EUR
Have any thoughts about
Bayer AG?
Write Note

Intrinsic Value

The intrinsic value of one BAYN stock under the Base Case scenario is 110.21 EUR. Compared to the current market price of 18.94 EUR, Bayer AG is Undervalued by 83%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BAYN Intrinsic Value
110.21 EUR
Undervaluation 83%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bayer AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BAYN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BAYN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about BAYN?
Bearish
Neutral
Bullish

Fundamental Analysis

18.94 EUR
+0.37%
+0.37%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Bayer AG
DE
Pharmaceuticals
Market Cap
18.6B EUR
IPO
Nov 28, 1997
Employees
99 637
Germany
Market Cap
18.6B EUR
Industry
Pharmaceuticals
IPO
Nov 28, 1997
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Bayer AG

Provide an overview of the primary business activities
of Bayer AG.

What unique competitive advantages
does Bayer AG hold over its rivals?

What risks and challenges
does Bayer AG face in the near future?

Has there been any significant insider trading activity
in Bayer AG recently?

Summarize the latest earnings call
of Bayer AG.

What significant events have occurred
in Bayer AG over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bayer AG.

Provide P/S
for Bayer AG.

Provide P/E
for Bayer AG.

Provide P/OCF
for Bayer AG.

Provide P/FCFE
for Bayer AG.

Provide P/B
for Bayer AG.

Provide EV/S
for Bayer AG.

Provide EV/GP
for Bayer AG.

Provide EV/EBITDA
for Bayer AG.

Provide EV/EBIT
for Bayer AG.

Provide EV/OCF
for Bayer AG.

Provide EV/FCFF
for Bayer AG.

Provide EV/IC
for Bayer AG.

Show me price targets
for Bayer AG made by professional analysts.

What are the Revenue projections
for Bayer AG?

How accurate were the past Revenue estimates
for Bayer AG?

What are the Net Income projections
for Bayer AG?

How accurate were the past Net Income estimates
for Bayer AG?

What are the EPS projections
for Bayer AG?

How accurate were the past EPS estimates
for Bayer AG?

What are the EBIT projections
for Bayer AG?

How accurate were the past EBIT estimates
for Bayer AG?

Compare the revenue forecasts
for Bayer AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bayer AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bayer AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bayer AG compared to its peers.

Compare the P/E ratios
of Bayer AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Bayer AG with its peers.

Analyze the financial leverage
of Bayer AG compared to its main competitors.

Show all profitability ratios
for Bayer AG.

Provide ROE
for Bayer AG.

Provide ROA
for Bayer AG.

Provide ROIC
for Bayer AG.

Provide ROCE
for Bayer AG.

Provide Gross Margin
for Bayer AG.

Provide Operating Margin
for Bayer AG.

Provide Net Margin
for Bayer AG.

Provide FCF Margin
for Bayer AG.

Show all solvency ratios
for Bayer AG.

Provide D/E Ratio
for Bayer AG.

Provide D/A Ratio
for Bayer AG.

Provide Interest Coverage Ratio
for Bayer AG.

Provide Altman Z-Score Ratio
for Bayer AG.

Provide Quick Ratio
for Bayer AG.

Provide Current Ratio
for Bayer AG.

Provide Cash Ratio
for Bayer AG.

What is the historical Revenue growth
over the last 5 years for Bayer AG?

What is the historical Net Income growth
over the last 5 years for Bayer AG?

What is the current Free Cash Flow
of Bayer AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bayer AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bayer AG

Current Assets 33.1B
Cash & Short-Term Investments 6.3B
Receivables 13.8B
Other Current Assets 13B
Non-Current Assets 73.8B
Long-Term Investments 3.1B
PP&E 13.2B
Intangibles 50.2B
Other Non-Current Assets 7.3B
Current Liabilities 25B
Accounts Payable 6.6B
Other Current Liabilities 18.5B
Non-Current Liabilities 51.3B
Long-Term Debt 36.7B
Other Non-Current Liabilities 14.7B
Efficiency

Earnings Waterfall
Bayer AG

Revenue
46.7B EUR
Cost of Revenue
-20B EUR
Gross Profit
26.7B EUR
Operating Expenses
-24.7B EUR
Operating Income
2B EUR
Other Expenses
-2.9B EUR
Net Income
-880m EUR

Free Cash Flow Analysis
Bayer AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BAYN Profitability Score
Profitability Due Diligence

Bayer AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
ROIC is Increasing
Positive 3-Years Revenue Growth
50/100
Profitability
Score

Bayer AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

BAYN Solvency Score
Solvency Due Diligence

Bayer AG's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average D/E
Positive Net Debt
30/100
Solvency
Score

Bayer AG's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BAYN Price Targets Summary
Bayer AG

Wall Street analysts forecast BAYN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BAYN is 28 EUR with a low forecast of 22.22 EUR and a high forecast of 42 EUR.

Lowest
Price Target
22.22 EUR
17% Upside
Average
Price Target
28 EUR
48% Upside
Highest
Price Target
42 EUR
122% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BAYN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BAYN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BAYN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

BAYN News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one BAYN stock?

The intrinsic value of one BAYN stock under the Base Case scenario is 110.21 EUR.

Is BAYN stock undervalued or overvalued?

Compared to the current market price of 18.94 EUR, Bayer AG is Undervalued by 83%.

Back to Top